JPMorgan Chase & Co’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
|
|||||
|
2025
Q1 | $861K | Buy |
|
|||||
|
2024
Q4 | $1.11M | Buy |
|
|||||
|
2024
Q3 | $2.45M | Buy |
|
|||||
|
2024
Q2 | $1.38M | Sell |
|
|||||
|
2024
Q1 | $1.47M | Sell |
|
|||||
|
2023
Q4 | $1.33M | Buy |
|
|||||
|
2023
Q3 | $1.5M | Buy |
|
|||||
|
2023
Q2 | $1.92M | Buy |
|
|||||
|
2023
Q1 | $954K | Buy |
|
|||||
|
2022
Q4 | $1.45M | Sell |
|
|||||
|
2022
Q3 | $1.9M | Buy |
|
|||||
|
2022
Q2 | $1.44M | Sell |
|
|||||
|
2022
Q1 | $2.39M | Buy |
|
|||||
|
2021
Q4 | $3.39M | Buy |
|
|||||
|
2021
Q3 | $5.42M | Buy |
|
|||||
|
2021
Q2 | $418K | Sell |
|
|||||
|
2021
Q1 | $7.3M | Buy |
|
|||||
|
2020
Q4 | $6.21M | Buy |
|
|||||
|
2020
Q3 | $5.82M | Buy |
|
|||||
|
2020
Q2 | $5.27M | Buy |
|
|||||
|
2020
Q1 | $91K | Buy |
|
|||||
|
2019
Q4 | $109K | Buy |
|